Franck Letourneur

9PUBLICATIONS
87CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMedical bacteriologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 28, 2025
Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.

Claire Delehouzé, Melodie Mallais, Arnaud Comte

|Oct 24, 2025
Genetic landscape of non-UV-induced cutaneous squamous cell carcinomas.

Carmen Al Youssef, Mansour Alkobtawi, Rémi Safi

|Oct 06, 2025
Impact of steroid differentiation on tumor microenvironment revealed by single-nucleus atlas of adrenal tumors.

Anne Jouinot, Yoann Martin, Florian Violon

|Aug 24, 2024
Somatic Molecular Heterogeneity in Bilateral Macronodular Adrenocortical Disease (BMAD) Differs Among the Pathological Subgroups.

Florian Violon, Lucas Bouys, Patricia Vaduva

|Feb 26, 2024
Type 1 interferons and Foxo1 down-regulation play a key role in age-related T-cell exhaustion in mice.

Aurélie Durand, Nelly Bonilla, Théo Level

|Oct 01, 2022
A unique Toxoplasma gondii haplotype accompanied the global expansion of cats.

Lokman Galal, Frédéric Ariey, Meriadeg Ar Gouilh

Pageof 2

Frequent Collaborators

2 joint publications

Mathilde Sibony

2 joint publications

Jérôme Bertherat

2 joint publications

Bruno Ragazzon

2 joint publications

Patricia Vaduva